Dietary TMAO supplementation exacerbates impaired glucose tolerance in high-fat diet-fed mice by disrupting hepatic insulin signaling and inducing adipose tissue inflammation, thereby elevating HOMA-IR indices (53). The gene discussed is INS; the disease is Impaired glucose tolerance.